Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd, an innovative medical diagnostics company, held its 2024 Annual General Meeting, emphasizing its focus on early cancer detection through its ColoSTAT® blood test. The company aims to reduce cancer mortality rates by providing a simple and affordable alternative to existing screening programs. With strong shareholder support, Rhythm continues to work towards the commercialisation and global distribution of its diagnostic solutions.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.